Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression

Medical Hypotheses

Volumn 69, Issue 1, 2007, Pages 132-135

  Pae, Chi Un ^a,b   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT; DOPAMINE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PROTEIN TYROSINE KINASE; SEROTONIN; UNCLASSIFIED DRUG;

ANXIETY; ARTICLE; BRAIN REGION; COGNITION; DEPRESSION; DRUG MECHANISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION;

EID: 34247597788     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.11.009     Document Type: Article

References (27)

1. Crown W.H., Finkelstein S., Berndt E.R., Ling D., Poret A.W., Rush A.J., et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 63 (2002) 963-971
2. Bourin M., David D.J., Jolliet P., and Gardier A. Mechanism of action of antidepressants and therapeutic perspectives. Therapie 57 (2002) 385-396
3. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58 (2006) 115-134
4. Wu B., Hu S., Yang M., Pan H., and Zhu S. CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor. Biochem Biophys Res Commun 347 (2006) 656-661
5. Douglass J., McKinzie A.A., and Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15 (1995) 2471-2481
6. Douglass J., and Daoud S. Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene 169 (1996) 241-245
7. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., and Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 93 (2005) 1551-1560
8. Smith S.M., Vaughan J.M., Donaldson C.J., Rivier J., Li C., Chen A., et al. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Endocrinology 145 (2004) 5202-5209
9. Gautvik K.M., de Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A., et al. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93 (1996) 8733-8738
10. Nielsen D.M. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?. Life Sci 78 (2006) 909-919
11. Baranowska B., Wolinska-Witort E., Bik W., Baranowska-Bik A., Martynska L., and Chmielowska M. The effect of cocaine-amphetamine regulated transcript (CART) on the activation of the pituitary-adrenal axis. Neuro Endocrinol Lett 27 (2006) 60-62
12. Stanley S.A., Small C.J., Murphy K.G., Rayes E., Abbott C.R., Seal L.J., et al. Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 893 (2001) 186-194
13. Koylu E.O., Balkan B., Kuhar M.J., and Pogun S. Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides 27 (2006) 1956-1969
14. Keck M.E. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 31 (2006) 241-250
15. Kuipers S.D., and Bramham C.R. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9 (2006) 580-586
16. Arantes-Goncalves F., and Coelho R. Depression and treatment. Apoptosis, neuroplasticity and antidepressants. Acta Med Port 19 (2006) 9-20
17. Lakatos A., Prinster S., Vicentic A., Hall R.A., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci Lett 384 (2005) 198-202
18. Koylu E.O., Couceyro P.R., Lambert P.D., and Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 391 (1998) 115-132
19. Smith Y., Koylu E.O., Couceyro P., and Kuhar M.J. Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys. Synapse 27 (1997) 90-94
20. Masand P.S., Anand V.S., and Tanquary J.F. Psychostimulant augmentation of second generation antidepressants: a case series. Depress Anxiety 7 (1998) 89-91
21. Masand P.S., and Tesar G.E. Use of stimulants in the medically ill. Psychiatr Clin North Am 19 (1996) 515-547
22. DeBattista C., Doghramji K., Menza M.A., Rosenthal M.H., and Fieve R.R. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 64 (2003) 1057-1064
23. Fava M., Thase M.E., and DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 66 (2005) 85-93
24. Moragues N., Ciofi P., Lafon P., Tramu G., and Garret M. GABAA receptor epsilon subunit expression in identified peptidergic neurons of the rat hypothalamus. Brain Res 967 (2003) 285-289
25. Harthoorn L.F., Sane A., Nethe M., and Van Heerikhuize J.J. Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol 25 (2005) 1209-1223
26. Shieh K.R. Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of central dopaminergic neurons. Neuropharmacology 44 (2003) 940-948
27. Vaarmann A., and Kask A. Cocaine and amphetamine-regulated transcript peptide (CART(62-76))-induced changes in regional monoamine levels in ratbrain. Neuropeptides 35 (2001) 292-296